Clinical Trial: A Dose-finding Study of Silodosin in Patients With Urinary Calculi

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Randomized, Double-blind, Placebo-controlled, Phase II Study of Silodosin in Patients With Urinary Calculi

Brief Summary: The purpose of this study is to evaluate the efficacy and the safety of silodosin in urinary calculi patients.

Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.

Current Primary Outcome: Spontaneous stone passage rate [ Time Frame: 4 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Time to spontaneous stone passage [ Time Frame: 4 weeks ]
  • Analgesic use [ Time Frame: 4 weeks ]
  • Pain severity [ Time Frame: 4 weeks ]


Original Secondary Outcome: Same as current

Information By: Kissei Pharmaceutical Co., Ltd.

Dates:
Date Received: February 21, 2012
Date Started:
Date Completion:
Last Updated: October 29, 2013
Last Verified: October 2013